Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.
Zhu X, Xu Y, Solis LM, Tao W, Wang L, Behrens C, Xu X, Zhao L, Liu D, Wu J, Zhang N, Wistuba II, Farokhzad OC, Zetter BR, Shi J.
Zhu X, et al. Among authors: liu d.
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7779-84. doi: 10.1073/pnas.1505629112. Epub 2015 Jun 8.
Proc Natl Acad Sci U S A. 2015.
PMID: 26056316
Free PMC article.